Mestag Therapeutics
Latest round
- Seed
Last raised
- Jul 2021
Total raised
- $41M
Investors
- 5
About Mestag Therapeutics
Founded in 2020 by co-founders Susan Hill and Mark Coles and based in Cambridge, UK, Mestag Therapeutics Limited is a developer of a fibroblast-immune cell for the treatment of cancer and inflammatory disease. Mestag’s pipeline includes MST-0300 and M402, both designed to target specific immune systems. MST-0300 is a bispecific antibody that enhances immune responses in solid tumours by activating fibroblast biology. This approach involves the conditional agonization of the lymphotoxin beta receptor in tumours, promoting the formation of tertiary lymphoid structures (TLS). M402 is another antibody in development, targeting a novel stromal checkpoint to modulate immune responses in inflammatory diseases. By enhancing the function of specific immune checkpoints to mitigate overactive immune responses in inflammatory conditions.
Who invested in Mestag Therapeutics
5 investors across 2 rounds
See all investors in Mestag Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mestag Therapeutics
Who invested in Mestag Therapeutics?
Mestag Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mestag Therapeutics raised?
Mestag Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mestag Therapeutics last raise money?
Mestag Therapeutics's most recent round on record is a Seed, in Jul 2021.
What does Mestag Therapeutics do?
Founded in 2020 by co-founders Susan Hill and Mark Coles and based in Cambridge, UK, Mestag Therapeutics Limited is a developer of a fibroblast-immune cell for the treatment of cancer and inflammatory disease.
Where is Mestag Therapeutics headquartered?
Mestag Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Mestag Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Mestag Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mestag Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.